| abstract |
In its many embodiments, the present invention provides a new class of midazo compounds (1,2-a (pyrazine as cyclin dependent kinase inhibitors, methods of preparing said compounds, pharmaceutical compositions containing one or more of said compounds, methods of preparing pharmaceutical formulations comprising one or more of said compounds, and methods of treatment, prevention, inhibition or improvement of one or more diseases associated with CDK, using said pharmaceutical compounds or compositions. |